Oncology & Cancer

New machine-learning method may aid personalized cancer therapy

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, ...

Medications

First-ever licencing deal struck for cancer drug

Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.

Diseases, Conditions, Syndromes

TGen and ABL pursue global rollout of advanced TB test

In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced ...

page 1 from 2